Riveira Mu xf1 oz E, Garcia Vidal E, Ba xf1 xf3 Polo M, Le xf3 n R, Blanc V, Clotet B, et al. Cetylpyridinium Chloride-Containing Mouthwashes Show Virucidal Activity against Herpes Simplex Virus Type 1. Viruses. 2023;15: pubmed publisher

Sorin M, Di Maio A, Silva L, Ebert D, Delannoy C, Nguyen N, et al. Structural and functional analysis of natural capsid variants suggests sialic acid-independent entry of BK polyomavirus. Cell Rep. 2023;42:112114 pubmed publisher

Harwood M, Woo T, Takeo Y, DiMaio D, Tsai B. HPV is a cargo for the COPI sorting complex during virus entry. Sci Adv. 2023;9:eadc9830 pubmed publisher

Molenberghs F, Verschuuren M, Barbier M, Bogers J, Cools N, Delputte P, et al. Cells infected with human papilloma pseudovirus display nuclear reorganization and heterogenous infection kinetics. Cytometry A. 2022;: pubmed publisher

Li M, Huang J, Zhu Y, Huang Z, Zhang G, Huang J. Anti-L1 antibody-bound HPV16 pseudovirus is degraded intracellularly via TRIM21/proteasomal pathway. Virol J. 2022;19:90 pubmed publisher

Shao S, A Ortega Rivera O, Ray S, K Pokorski J, F Steinmetz N. A Scalable Manufacturing Approach to Single Dose Vaccination against HPV. Vaccines (Basel). 2021;9: pubmed publisher

Harwood M, Dupzyk A, Inoue T, DiMaio D, Tsai B. p120 catenin recruits HPV to γ-secretase to promote virus infection. PLoS Pathog. 2020;16:e1008946 pubmed publisher

Mboumba Bouassa R, Pere H, Gubavu C, Prazuck T, Jenabian M, Veyer D, et al. Serum and cervicovaginal IgG immune responses against α7 and α9 HPV in non-vaccinated women at risk for cervical cancer: Implication for catch-up prophylactic HPV vaccination. PLoS ONE. 2020;15:e0233084 pubmed publisher

Porter S, McBride A. Human Papillomavirus Quasivirus Production and Infection of Primary Human Keratinocytes. Curr Protoc Microbiol. 2020;57:e101 pubmed publisher

Buck C, Thompson C, Roberts J, Muller M, Lowy D, Schiller J. Carrageenan is a potent inhibitor of papillomavirus infection. PLoS Pathog. 2006;2:e69 pubmed